ArticleMicromachines2026
Portable and Point-of-Care Testing Approach for Determining Soil Extracellular Enzyme Activities.
Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Soil eco-enzymes (i.e., microbial extracellular enzymes) play essential roles in terrestrial nutrient cycling and support ecosystem services. In this regard, their activities serve as indicators of soil health. However, conventional spectrophotometric and microplate fluorometric assays are often limited by lengthy reaction procedures, relatively high reagent consumption, and insufficient compatibility with complex soil matrices. In this investigation, we developed a portable, centrifugally driven microfluidic chip for the rapid and sensitive determination of multiple soil extracellular enzyme activities. This integrated platform automated sample aliquoting, reagent metering, mixing, and sedimentation, enabling the parallel measurement of eight enzymes. Such system demonstrated precise liquid control via capillary valves and high optical uniformity (<5% fluorescence variation). 4-methylumbelliferone (MUF)-based calibration exhibited strong linearity (R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.